15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma
28 February 2018
15-year-old melanoma survivor Toby Rayner will lead Mount Gambier’s march against melanoma. Julie-Ann Sams knows all too well that melanoma doesn’t discriminate. Life changed for her youngest son, Toby Rayner, when he was diagnosed with a rare from of iris melanoma that sadly required his left eye to be surgically removed.
Toby’s story began at his local optometrist when, in late 2014, his optometrist noticed a small
freckle in his left eye. The optometrist told Julie-Ann to keep an eye on it in case it started to cause problems. It wasn’t until August 2015 that Toby started to complain about pain in his eye and difficulty reading the board at school. It was at that point that Julie-Ann worried it might be something more than just a freckle.
Toby’s optometrist examined his eye and referred him to an ophthalmologist who then referred him to an oncologist in Melbourne for further tests. The oncologist performed a biopsy on the freckle, and unfortunately the results revealed Toby had a rare form of iris melanoma, which would require his eye to be removed.
On November 30, just three days before his thirteenth birthday, Toby had his left eye removed.
It was a life-changing event, yet Toby hasn’t let his melanoma diagnosis get him down, showing incredible bravery throughout his melanoma journey and only taking two weeks off school following his surgery.
Julie-Ann has been blown away by the support of her friends and the community, with Toby’s best friend Josh Telford shaving his head and his family hosting fundraisers to help support the family through Toby’s journey.
“My family and I only moved to Mount Gambier six years ago and we are forever grateful for the
support we’ve received from the community. We can’t thank them enough for getting us through
this difficult time,” says Julie-Ann.
Julie-Ann says she hopes this year’s Melanoma March raises awareness about melanoma and the importance of getting regular checks. This year 14,000 Australians will be told they have melanoma, one of the highest rates in the world.
Toby will be cutting the ribbon and leading out the Mount Gambier Melanoma March on 4 March to raise funds for life-saving research and to try and change that statistic for all Australians. “Melanoma doesn’t discriminate - it can affect anyone at any time. Its not just an older person’s disease; Toby is testament to that,” says Julie-Ann.
“Even if you’re sun smart, melanoma can still affect you.I It’s so important to be aware and act fast on anything you think looks suspicious as it might just save your life,” adds Julie-Ann.
Join Toby in the fight against melanoma by signing up for a Melanoma March event near you.
Little Madi misses her Dad. But she is determined to honour his memory and support life-saving melanoma research.
Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!
MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.